Stay updated on Seagen Press Releases
Sign up to get notified when there's something new on the Seagen Press Releases page.

Latest updates to the Seagen Press Releases page
- Check5 days agoChange DetectedThe webpage has updated its content to include new announcements from Pfizer regarding positive clinical trial results and upcoming financial events, while removing previous updates about similar topics.SummaryDifference1%
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe webpage has been updated to include new research findings and corporate announcements from Pfizer, particularly regarding advancements in cancer treatment and vaccine recommendations. Notably, the deletion of previous announcements indicates a shift in focus towards more recent developments.SummaryDifference3%
- Check34 days agoChange DetectedThe webpage has been updated to include new press releases from Pfizer, highlighting significant developments in their research and financial performance, including long-term survival data for XTANDI™ and updates on their RSV vaccine. Notably, the page has removed previous entries related to similar topics, indicating a shift in focus to more recent information.SummaryDifference100%
- Check41 days agoChange DetectedThe webpage has updated its content to reflect a new corporate licensing agreement involving Pfizer and 3SBio, while removing a previous announcement about a healthcare conference webcast.SummaryDifference11%
- Check62 days agoChange DetectedThe webpage has been updated with new financial results and advancements in cancer treatment by Pfizer, while several previous announcements regarding drug approvals and clinical trial results have been removed.SummaryDifference50%
- Check70 days agoChange DetectedThe page now includes an important update regarding the expansion of the recommendation for Pfizer’s RSV vaccine to include adults aged 50 to 59 at increased risk of disease. However, it has removed a specific date and a previous announcement about Pfizer's advancements in genitourinary cancers.SummaryDifference13%
Stay in the know with updates to Seagen Press Releases
Enter your email address, and we'll notify you when there's something new on the Seagen Press Releases page.